Baxter International Inc.

Equities

BAX

US0718131099

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-05-17 pm EDT			5-day change	1st Jan Change
35.25 ^USD	+0.23%		-1.23%	-8.82%

May. 16	Transcript : Baxter International Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM
May. 13	Baxter International's Clinolipid Injection Approved for Expanded Use in US	MT

Baxter International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 02, 2024 at 07:21 am EDT

Baxter International Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 3,592 million compared to USD 3,513 million a year ago. Net income was USD 37 million compared to USD 44 million a year ago.

Basic earnings per share from continuing operations was USD 0.07. Diluted earnings per share from continuing operations was USD 0.07. Basic earnings per share was USD 0.07 compared to USD 0.09 a year ago.

Diluted earnings per share was USD 0.07 compared to USD 0.09 a year ago.

Latest news about Baxter International Inc.

Transcript : Baxter International Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM	May. 15
Baxter International's Clinolipid Injection Approved for Expanded Use in US	May. 13	MT
TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40	May. 10	MT
Declaration of Voting Results by Baxter International Inc	May. 09	CI
Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31	May. 07	MT
Baxter International Inc. Declares Quarterly Dividend, Payable on July 1, 2024	May. 07	CI
UBS Adjusts Price Target on Baxter International to $40 From $42, Maintains Neutral Rating	May. 03	MT
Evercore ISI Adjusts Price Target on Baxter International to $46 From $50	May. 03	MT
Jefferies Adjusts Price Target on Baxter International to $43 From $45	May. 03	MT
Stifel Adjusts Baxter International's Price Target to $44 From $50	May. 02	MT
Baxter International Q1 Adjusted Earnings, Net Sales Gain; Boosts 2024 Adjusted Profit Guidance	May. 02	MT
Transcript : Baxter International Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
(BAX) BAXTER INTERNATIONAL Forecasts Q2 Adjusted EPS Range $0.65 - $0.67	May. 02	MT
(BAX) BAXTER INTERNATIONAL Sees Fiscal Year 2024 Adjusted EPS Range $2.88 - $2.98	May. 02	MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Adjusted EPS $0.65 vs. $0.61 Estimate	May. 02	MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B	May. 02	MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B	May. 02	MT
Baxter International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Baxter International Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024	May. 02	CI
North American Morning Briefing : Stock Futures -2-	May. 02	DJ
Edwards Lifesciences Corporation: The story continues	Apr. 23
Exact Sciences Names Aaron Bloomer CFO	Apr. 15	MT
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S	Apr. 11	CI
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period	Apr. 04	MT
Citigroup Raises Price Target on Baxter International to $44 From $41, Keeps Neutral Rating	Apr. 03	MT

Chart Baxter International Inc.

Duration

Period

More charts

Company Profile

Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-30 - Ex-dividend day

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Baxter International Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

35.25 USD

Average target price

46.47 USD

Spread / Average Target

+31.82%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BAXTER INTERNATIONAL INC.	-8.82%	17.96B
ABBOTT LABORATORIES	-5.43%	181B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.29B
DEXCOM, INC.	+5.86%	52.24B
CENCORA, INC.	+8.15%	44.3B
HOYA CORPORATION	+7.52%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.52B
TERUMO CORPORATION	+17.85%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.91B

Other Medical Equipment, Supplies & Distribution